Spots Global Cancer Trial Database for stage iva colon cancer ajcc v7

Every month we try and update this database with for stage iva colon cancer ajcc v7 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery	NCT03365882	Colon Adenocarc... ERBB2 Gene Ampl... Rectal Adenocar... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IIIA Colo... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Rect... Stage IV Colon ... Stage IV Rectal... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta...	Cetuximab Irinotecan Hydr... Laboratory Biom... Pertuzumab Trastuzumab HER-2 testing	18 Years -	SWOG Cancer Research Network
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer	NCT04294264	Metastatic Colo... Recurrent Colon... Refractory Colo... Stage IV Colon ... Stage IVA Colon... Stage IVB Colon...	Oxaliplatin Trifluridine an...	18 Years -	Rutgers, The State University of New Jersey
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy	NCT02381561	Advanced Bile D... Stage II Esopha... Stage II Pancre... Stage IIA Esoph... Stage IIA Pancr... Stage IIB Esoph... Stage IIB Pancr... Stage III Colon... Stage III Esoph... Stage III Gastr... Stage III Liver... Stage III Pancr... Stage III Recta... Stage III Small... Stage IIIA Colo... Stage IIIA Esop... Stage IIIA Gast... Stage IIIA Rect... Stage IIIA Smal... Stage IIIB Colo... Stage IIIB Esop... Stage IIIB Gast... Stage IIIB Rect... Stage IIIB Smal... Stage IIIC Colo... Stage IIIC Esop... Stage IIIC Gast... Stage IIIC Rect... Stage IV Colon ... Stage IV Esopha... Stage IV Gastri... Stage IV Liver ... Stage IV Pancre... Stage IV Rectal... Stage IV Small ... Stage IVA Colon... Stage IVA Liver... Stage IVA Recta... Stage IVB Colon... Stage IVB Liver... Stage IVB Recta...	Intensity-Modul... Laboratory Biom... Pharmacological... Ropidoxuridine	18 Years -	National Cancer Institute (NCI)
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer	NCT04294264	Metastatic Colo... Recurrent Colon... Refractory Colo... Stage IV Colon ... Stage IVA Colon... Stage IVB Colon...	Oxaliplatin Trifluridine an...	18 Years -	Rutgers, The State University of New Jersey
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy	NCT02381561	Advanced Bile D... Stage II Esopha... Stage II Pancre... Stage IIA Esoph... Stage IIA Pancr... Stage IIB Esoph... Stage IIB Pancr... Stage III Colon... Stage III Esoph... Stage III Gastr... Stage III Liver... Stage III Pancr... Stage III Recta... Stage III Small... Stage IIIA Colo... Stage IIIA Esop... Stage IIIA Gast... Stage IIIA Rect... Stage IIIA Smal... Stage IIIB Colo... Stage IIIB Esop... Stage IIIB Gast... Stage IIIB Rect... Stage IIIB Smal... Stage IIIC Colo... Stage IIIC Esop... Stage IIIC Gast... Stage IIIC Rect... Stage IV Colon ... Stage IV Esopha... Stage IV Gastri... Stage IV Liver ... Stage IV Pancre... Stage IV Rectal... Stage IV Small ... Stage IVA Colon... Stage IVA Liver... Stage IVA Recta... Stage IVB Colon... Stage IVB Liver... Stage IVB Recta...	Intensity-Modul... Laboratory Biom... Pharmacological... Ropidoxuridine	18 Years -	National Cancer Institute (NCI)
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer	NCT01254617	Recurrent Colon... Recurrent Hypop... Recurrent Laryn... Recurrent Laryn... Recurrent Lip a... Recurrent Metas... Recurrent Nasal... Recurrent Nasop... Recurrent Oral ... Recurrent Oroph... Recurrent Recta... Recurrent Saliv... Salivary Gland ... Squamous Cell C... Stage IV Hypoph... Stage IV Nasoph... Stage IVA Colon... Stage IVA Laryn... Stage IVA Laryn... Stage IVA Lip a... Stage IVA Major... Stage IVA Nasal... Stage IVA Oral ... Stage IVA Oroph... Stage IVA Recta... Stage IVB Colon... Stage IVB Laryn... Stage IVB Laryn... Stage IVB Lip a... Stage IVB Major... Stage IVB Nasal... Stage IVB Oral ... Stage IVB Oroph... Stage IVB Recta... Stage IVC Laryn... Stage IVC Laryn... Stage IVC Lip a... Stage IVC Major... Stage IVC Nasal... Stage IVC Oral ... Stage IVC Oroph... Tongue Carcinom...	Cetuximab Laboratory Biom... Lenalidomide	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: